Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 419853, 11 pages
Research Article

Diagnostic and Prognostic Value of Soluble Syndecan-1 in Pleural Malignancies

1Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, F46, Huddinge University Hospital, 141 86 Stockholm, Sweden
2Division of Cognitive Neurophysiology and Osher Center for Integrative Medicine, Department of Clinical Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden
3Stress Research Center, Stockholm University, 106 91 Stockholm, Sweden
4Department of Chest Diseases, Eskisehir Osmangazi University Medical Faculty, 260 40 Eskisehir, Turkey

Received 9 May 2014; Accepted 30 June 2014; Published 24 July 2014

Academic Editor: Dragana Nikitovic

Copyright © 2014 Filip Mundt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Figure S1: The correlation between syndecan-1 and osteopontin in pleural effusions and serum.

Figure S2: Continuous hazard ratios of syndecan-1 and osteopontin for the determination of optimal survival curves.

Figure S3: The diagnostic value of syndecan-1 in patient subgroups.

  1. Supplementary Material